Skip to the page

Data / Drug companies / Advanced Rx LLC

Advanced Rx LLC: 40 products in the FDA NDC directory, labeler code 80513

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Advanced Rx LLC (labeler code 80513) lists 40 products in the FDA National Drug Code Directory, covering 29 finished drugs by generic name. By type: 40 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on February 1, 2026.

The request: Watch Advanced Rx LLC (FDA labeler code 80513): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
80513
Products in commercial distribution
40
Packages
43
Finished drugs by generic name
29
Prescription products
0
Over the counter products
40
Flagged as original packager
39 of 39 products that carry the flag
Started marketing in the last 12 months
2
Products with a marketing end date set
4
Earliest marketing start
August 27, 2004
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs3177.5%
Generic drugs (ANDA)820%
Other unapproved drugs12.5%

Products by type

TypeProductsShare
Over the counter drugs40100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet1435%
Capsule, liquid filled820%
Capsule, gelatin coated410%
Liquid37.5%
Tablet, delayed release37.5%
Tablet, extended release25%
Patch12.5%
Tablet, coated12.5%
Tablet, chewable12.5%
Powder12.5%
Cream12.5%
Tablet, film coated12.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Gas Relief Ultimate Strength Softgels80513-119Capsule, liquid filledOver the counter monograph drugsFebruary 1, 2026
Puregen Labs Acetaminophen80513-001LiquidOver the counter monograph drugsDecember 1, 2025
Sodium Bicarbonate 10 GR (650 MG)80513-611TabletOver the counter monograph drugsSeptember 1, 2025
Meclizine80513-427TabletOver the counter monograph drugsSeptember 1, 2025
Extra Strength Headache Relief80513-362TabletOver the counter monograph drugsJuly 1, 2025
Nasal Decongestant PE80513-789TabletOver the counter monograph drugsJune 1, 2025
Cetirizine hydrochloride80513-731Tablet, coatedGeneric drugs (ANDA)May 1, 2025
Aspirin 81mg Enteric Coated80513-287Tablet, delayed releaseOver the counter monograph drugsMay 1, 2025
Anti-diarrheal80513-375TabletGeneric drugs (ANDA)January 3, 2025
Antifungal80513-771PowderOver the counter monograph drugsJanuary 1, 2025
Sodium Chloride Normal Salt80513-608TabletOver the counter monograph drugsJanuary 1, 2025
Laxative80513-409Tablet, delayed releaseOver the counter monograph drugsJanuary 1, 2025
Mucus relief dm80513-407TabletOver the counter monograph drugsJanuary 1, 2025
Multi-Symptom Nighttime Cold and Flu Relief80513-316Capsule, liquid filledOver the counter monograph drugsJanuary 1, 2025
Cough Relief80513-311Capsule, liquid filledOver the counter monograph drugsJanuary 1, 2025
Gas Relief80513-117Capsule, liquid filledOver the counter monograph drugsJanuary 1, 2025
Meclizine80513-421Tablet, chewableOver the counter monograph drugsDecember 1, 2024
Adult Low Dose Aspirin80513-289Tablet, delayed releaseOver the counter monograph drugsDecember 1, 2024
Puregen Labs Allergy Relief80513-201LiquidOver the counter monograph drugsDecember 1, 2024
Gas Relief80513-112Capsule, liquid filledOver the counter monograph drugsAugust 30, 2024
Gas Relief80513-111Capsule, liquid filledOver the counter monograph drugsAugust 30, 2024
Senna-s80513-105TabletOver the counter monograph drugsAugust 28, 2024
Allergy Relief80513-722TabletOver the counter monograph drugsAugust 1, 2024
Night time sleep-aid80513-383TabletOver the counter monograph drugsAugust 1, 2024
PUREGEN LABS Pain Relief 4 Lidocaine80513-814PatchOver the counter monograph drugsJune 3, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.